Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP4394584B2 - Drug diffusion device - Google Patents
[go: Go Back, main page]

JP4394584B2 - Drug diffusion device - Google Patents

Drug diffusion device Download PDF

Info

Publication number
JP4394584B2
JP4394584B2 JP2005003913A JP2005003913A JP4394584B2 JP 4394584 B2 JP4394584 B2 JP 4394584B2 JP 2005003913 A JP2005003913 A JP 2005003913A JP 2005003913 A JP2005003913 A JP 2005003913A JP 4394584 B2 JP4394584 B2 JP 4394584B2
Authority
JP
Japan
Prior art keywords
drug
container
port
box body
exhaust port
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2005003913A
Other languages
Japanese (ja)
Other versions
JP2006191960A (en
Inventor
英夫 大西
功 大橋
Original Assignee
株式会社ノックスラボラトリーズ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社ノックスラボラトリーズ filed Critical 株式会社ノックスラボラトリーズ
Priority to JP2005003913A priority Critical patent/JP4394584B2/en
Publication of JP2006191960A publication Critical patent/JP2006191960A/en
Application granted granted Critical
Publication of JP4394584B2 publication Critical patent/JP4394584B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)

Description

本発明は、殺菌剤、脱臭剤、芳香剤を拡散させる薬剤拡散装置に関するものである。   The present invention relates to a drug diffusing device for diffusing a bactericide, a deodorant, and a fragrance.

従来、食品加工や医薬品製造等のための無菌室を殺菌・除菌する際には、無菌室に供給する空気をクリーンフィルタにより濾過してゴミ・塵等と共に細菌、カビ等を取り除き、又、同時に無菌室内の機器や床を、泡発生洗浄剤や熱湯噴射で洗浄し、乾燥の後、次亜塩素酸ナトリウム、塩化ベンザルコニュウム製剤等を溶液噴霧して殺菌・除菌することが一般に普及している。   Conventionally, when sterilizing and sterilizing an aseptic room for food processing, pharmaceutical manufacturing, etc., the air supplied to the aseptic room is filtered through a clean filter to remove bacteria, mold, etc. along with dust, dust, etc. It is generally popular to sterilize and disinfect aseptic room equipment and floors with foam-generating detergent or hot water jet, and after drying, spray with sodium hypochlorite, benzalconium chloride preparation, etc. is doing.

他の方法としては、紫外線照射による所定の波長帯で殺菌・除菌するものや、オゾン発生装置によるオゾンガスで殺菌・除菌するものがある。   Other methods include sterilization and sterilization in a predetermined wavelength band by ultraviolet irradiation, and sterilization and sterilization with ozone gas from an ozone generator.

更に別の方法としては、紫外線ランプと安定化二酸化塩素含有剤により二酸化塩素ガスを発生させると共に、ファンにより吸気口から排気口へ向かう気流を形成して二酸化塩素ガスを拡散させ、殺菌・除菌するものがある(例えば、特許文献1参照)。
特開2000−202009号公報
As another method, chlorine dioxide gas is generated by an ultraviolet lamp and a stabilized chlorine dioxide containing agent, and an air flow from the intake port to the exhaust port is formed by a fan to diffuse the chlorine dioxide gas, thereby sterilizing and disinfecting. (For example, refer to Patent Document 1).
JP 2000-202009 A

しかしながら、クリーンフィルタにより殺菌・除菌する場合には、空気の殺菌・除菌には有効であるが、室内の機器や床には効果がなく、上記の如く他の薬剤を併用しなければならないという問題があった。又、紫外線照射で殺菌・除菌する場合には、室内の空気や直接照射される部分には殺菌・除菌の効果が認められるが、機器や部品等の裏面や隙間などの部分には効果がないという問題があった。更に、オゾンガスで殺菌・除菌する場合には、蛋白質等の有機物に対して効果が弱く、特有の臭いを生じると共に、オゾンによる発ガン性の心配があった。更に又、二酸化塩素ガスを発生させて殺菌・除菌する場合には、二酸化塩素の比重が空気よりやや重く、二酸化塩素ガスの拡散性が弱いため、薬剤の濃度を均一して室内の隅々に到達させることが容易でないと共に、微生物を死滅させる濃度に上げるまでに相当の時間がかかるという問題があった。   However, when sterilizing and sterilizing with a clean filter, it is effective for sterilizing and sterilizing air, but it is not effective for indoor equipment and floors, and other drugs must be used in combination as described above. There was a problem. In addition, when sterilizing and sterilizing with ultraviolet irradiation, the effect of sterilization and sterilization is recognized in indoor air and directly irradiated parts, but it is effective in the backside and gaps of equipment and parts. There was no problem. Further, when sterilizing and sterilizing with ozone gas, the effect on organic substances such as proteins is weak, a specific odor is generated, and there is a concern about carcinogenicity due to ozone. Furthermore, when chlorine dioxide gas is generated for sterilization and sterilization, the specific gravity of chlorine dioxide is slightly heavier than air and the diffusibility of chlorine dioxide gas is weak. It is not easy to reach the concentration, and there is a problem that it takes a considerable time to increase the concentration to kill microorganisms.

本発明は、上述の実情に鑑み、薬剤を迅速に拡散させる薬剤拡散装置を提供することを目的とするものである。   In view of the above circumstances, an object of the present invention is to provide a drug diffusion device that rapidly diffuses a drug.

本発明は、薬剤を収容し且つ上方に開放口を形成した容器と、該容器を交換可能に配置するボックス本体と、前記ボックス本体内部で前記容器の上方に対向配置される紫外線ランプと、前記ボックス本体に設置される排気ファンとを備え、
前記容器に入れる薬剤を、二酸化塩素溶液又は二酸化塩素を溶存させたゲル状固形物のいずれかにし、
前記ボックス本体に、空気を外部から供給する吸気口を設けることなく、排気ファンを備えた排気口のみを設けて二酸化塩素ガスを外部へ拡散させると共に、前記排気口を、容器の開放口よりも下方に配したことを特徴とする薬剤拡散装置、にかかわるものである。
The present invention includes a container that contains a medicine and has an opening formed above, a box body in which the container is replaceably disposed, an ultraviolet lamp that is disposed above the container inside the box body , An exhaust fan installed in the box body,
The drug placed in the container is either a chlorine dioxide solution or a gel-like solid in which chlorine dioxide is dissolved,
Without providing an air inlet for supplying air from the outside to the box body , only an exhaust port provided with an exhaust fan is provided to diffuse chlorine dioxide gas to the outside, and the exhaust port is more than the opening of the container. The present invention relates to a drug diffusion device characterized by being arranged below .

本発明において、ボックス本体の開閉ドアを密閉可能にすることが好ましい。   In the present invention, it is preferable that the opening / closing door of the box body can be sealed.

このように、本発明の薬剤拡散装置によれば、ボックス本体に、空気を外部から供給する吸気口を設けることなく、排気ファンを備えた排気口のみを設けて二酸化塩素ガスを外部へ拡散させるので、吸気口及び排気口を備えて排気ファンにより二酸化塩素ガスを拡散させる場合に比べ、二酸化塩素ガスを好適に拡散させ、結果的に、二酸化塩素ガスの濃度を容易に上げることができる。 As described above, according to the medicine diffusing device of the present invention, the box body is provided with only the exhaust port provided with the exhaust fan without diffusing the chlorine dioxide gas to the outside without providing the intake port for supplying air from the outside. Therefore, compared with the case where the chlorine dioxide gas is diffused by the exhaust fan provided with the intake port and the exhaust port, the chlorine dioxide gas is preferably diffused, and as a result, the concentration of the chlorine dioxide gas can be easily increased.

又、排気口を、容器の開放口よりも下方に配置すると、排気口を容器の開放口より上方に配置した場合に比べて、二酸化塩素ガスを迅速に拡散させ、結果的に、二酸化塩素ガスの濃度を容易且つ好適に均一化すると共に、二酸化塩素ガスの濃度に上げるまでの時間を一層短縮することができる。 Further, an exhaust port and arranged below the mouth opening of the container, as compared with the case where the exhaust port is disposed above the mouth opening of the container and to quickly diffuse the chlorine dioxide gas, consequently, chlorine dioxide gas It is possible to easily and suitably equalize the concentration of gas and to further shorten the time required to increase the concentration of chlorine dioxide gas .

ボックス本体の開閉ドアを密閉可能にすると、ボックス本体の真空度を高めるので、二酸化塩素ガスを一層好適に拡散させることができる。 If the opening / closing door of the box body can be sealed, the degree of vacuum of the box body is increased, so that chlorine dioxide gas can be more suitably diffused.

容器に入れる薬剤を、二酸化塩素溶液又は二酸化塩素を溶存させたゲル状固形物のいずれかにすると、クリーンフィルタの如く他の殺菌・除菌剤を併用することを不要にし、空気は勿論、機器や部品等の裏面や隙間などの部分であっても好適に殺菌・除菌することができる。又、二酸化塩素ガスによれば、汚染された作業台や食品を好適に殺菌・除菌すると共に、汚染により発生する臭いを抑制することができる。   If the medicine to be put in the container is either a chlorine dioxide solution or a gel-like solid substance in which chlorine dioxide is dissolved, it becomes unnecessary to use other sterilizing / disinfecting agents like a clean filter. Even parts such as back surfaces and gaps of parts can be suitably sterilized and sterilized. Moreover, according to the chlorine dioxide gas, it is possible to suitably sterilize and disinfect the contaminated work table and food, and to suppress the odor generated by the contamination.

以上説明したように、本発明の薬剤拡散装置によれば、薬剤を好適に拡散させることができるという優れた効果を奏し得る。   As described above, according to the drug diffusing device of the present invention, an excellent effect that the drug can be suitably diffused can be obtained.

以下、本発明の実施の形態を図面に基いて説明する。   Hereinafter, embodiments of the present invention will be described with reference to the drawings.

図1〜図4は本発明を実施する形態例を示すものである。 1 to 4 show an embodiment for carrying out the present invention.

実施の形態例の薬剤拡散装置1は、内部空間を形成するボックス本体2を備え、ボックス本体2の内部下面には、所定高さを有する架台3を設置し、架台3の上面には、上方に開放口4を形成したプラスチックもしくは金属製の容器5を交換可能に配置している。ここで、容器5は、直径15〜30cmの径の開放口4を有する円柱形か、それに近い開放口4を有する直方体で形成されており、容器5の内部には、2×10ppmから3×10ppmの濃度、好ましくは5×10ppmから2×10ppmの濃度の二酸化塩素溶液又は二酸化塩素を溶存させたゲル状固形物のいずれかの薬剤を収容している。なお、薬剤の種類は二酸化塩素以外でも、例えば、安定化二酸化塩素とアルコール、脱臭剤、芳香剤等の混合物でもよい。 The drug diffusing device 1 according to the embodiment includes a box body 2 that forms an internal space. A gantry 3 having a predetermined height is installed on the inner lower surface of the box main body 2. A plastic or metal container 5 having an opening 4 formed therein is replaceably disposed. Here, the container 5 is formed in a cylindrical shape having an open port 4 having a diameter of 15 to 30 cm or a rectangular parallelepiped having an open port 4 close thereto, and the inside of the container 5 has a density of 2 × 10 3 ppm. It contains either a chlorine dioxide solution having a concentration of 3 × 10 4 ppm, preferably a concentration of 5 × 10 3 ppm to 2 × 10 4 ppm, or a gel-like solid in which chlorine dioxide is dissolved. In addition, the kind of chemical | medical agent may be other than chlorine dioxide, for example, may be a mixture of stabilized chlorine dioxide and alcohol, deodorant, fragrance or the like.

ボックス本体2の内部天井には、容器5の開放口4の上方に所定の間隔を介して対向配置されるよう紫外線ランプ6を配置している。ここで紫外線ランプ6は、二酸化塩素ガスを安全な濃度で発生させるよう10W〜100Wのものを使用し、好ましくは15W〜30Wのものを使用している。   An ultraviolet lamp 6 is disposed on the inner ceiling of the box body 2 so as to be opposed to the opening 5 of the container 5 with a predetermined interval. Here, as the ultraviolet lamp 6, a lamp of 10 W to 100 W, preferably 15 W to 30 W, is used so as to generate chlorine dioxide gas at a safe concentration.

ボックス本体2の側方正面の下部には、空気を外部と流通させる流通口を形成するよう、排気ファン7を備えた排気口8を備えている。ここで排気ファン7は、容器5の開放口4よりも下方に位置して風向きをボックス本体2の内部から外部へ向けるようにし、又、回転数を毎分1×10回転〜5×10回転にし、風量を毎分0.5m〜10.0m、好ましくは毎分1.0m〜3.0mにしている。なお、排気ファン7を備えた排気口8は、ボックス本体2の底面に配置してもよい。 An exhaust port 8 including an exhaust fan 7 is provided in a lower portion of the front side of the box body 2 so as to form a circulation port through which air is circulated to the outside. Here, the exhaust fan 7 is positioned below the opening 4 of the container 5 so that the air direction is directed from the inside of the box body 2 to the outside, and the rotation speed is 1 × 10 3 rotations to 5 × 10 5 minutes per minute. 3 to rotate, every minute air volume 0.5 m 3 ~10.0M 3, preferably in the min 1.0m 3 ~3.0m 3. The exhaust port 8 provided with the exhaust fan 7 may be disposed on the bottom surface of the box body 2.

ボックス本体2の床面で架台3の下部には、紫外線ランプ6及び排気ファン7に接続される電気制御部9を配置しており、電気制御部9は、ボックス本体2の正面下部にスイッチ10を備えると共に内部にタイマー機構と安全機構とを備え、タイマー機構は、紫外線ランプ6の照射時間等や排気ファン7の駆動時間等を制御すると共に、安全機構は、雷等により過電流が流れた場合に安全に対応し得るようにしている。ここで、電気制御部9は、外部の電源(図示せず)に配線(図示せず)を介して接続されており、外部の電源に接続される配線は、ボックス本体2の裏面に形成された配線口(図示せず)を通すようになっている。なお、配線口は、耐薬品性のパッキン等で穴埋めすることが好ましい。   An electric control unit 9 connected to the ultraviolet lamp 6 and the exhaust fan 7 is arranged on the floor surface of the box main body 2 at the lower part of the gantry 3. And a timer mechanism and a safety mechanism inside. The timer mechanism controls the irradiation time of the ultraviolet lamp 6, the driving time of the exhaust fan 7, etc., and the safety mechanism has an overcurrent caused by lightning or the like. It is possible to respond safely in case. Here, the electric control unit 9 is connected to an external power source (not shown) via wiring (not shown), and the wiring connected to the external power source is formed on the back surface of the box body 2. Through the wiring port (not shown). The wiring port is preferably filled with a chemical resistant packing or the like.

又、ボックス本体2の正面上部もしくは側面上部には、ドアノブ11を備えて開閉し得る開閉ドア12を備えており、開閉ドア12は、周囲に耐薬品性ゴムパッキンやシリコン樹脂の密着材を配し、ボックス本体2に対して密閉可能にしている。   The box body 2 is provided with an opening / closing door 12 that can be opened and closed with a door knob 11 at the front upper portion or side surface upper portion, and the opening / closing door 12 is provided with a chemical-resistant rubber packing or a silicone resin adhesion material around it. The box body 2 can be sealed.

以下、本発明を実施する形態例の作用を説明する。 The operation of the embodiment for carrying out the present invention will be described below.

実施の形態例の薬剤拡散装置1を使用して殺菌する場合には、予め、ボックス本体2内の架台3に、薬剤を収容した容器5を配置し、食品加工室等の殺菌しようとする室内13の壁面上部に、排気口8が室内13側に向くよう薬剤拡散装置1を配置し、室内13の出入口14の扉15を閉じる。 In the case of sterilization using the drug diffusion device 1 of the embodiment, the container 5 containing the drug is placed in advance on the gantry 3 in the box body 2 and the room to be sterilized such as a food processing room. The drug diffusing device 1 is arranged on the upper wall surface of the wall 13 so that the exhaust port 8 faces toward the room 13, and the door 15 of the doorway 14 of the room 13 is closed.

続いて、薬剤拡散装置1を無人の状態で駆動させるよう、作業終了後や清掃終了後にスイッチ10を入れ、電気制御部9のタイマを作動させると共に、紫外線ランプ6及び排気ファン7に電源を供給する。   Subsequently, the switch 10 is turned on after the operation or cleaning is completed so that the drug diffusion device 1 is driven unattended, the timer of the electric control unit 9 is activated, and the power is supplied to the ultraviolet lamp 6 and the exhaust fan 7. To do.

電源を紫外線ランプ6及び排気ファン7に供給すると、紫外線ランプ6は、ボックス本体2内で紫外線を容器5の薬剤に向けて照射することにより、薬剤をガス化して除菌ガス、脱臭ガス又は芳香ガスを発生させ、同時に排気ファン7は、回転駆動することにより、ボックス本体2内で発生した除菌ガス等を排気口8のみを介してボックス本体2から室内13へ拡散させる。   When power is supplied to the ultraviolet lamp 6 and the exhaust fan 7, the ultraviolet lamp 6 irradiates ultraviolet rays toward the chemical in the container 5 in the box body 2, thereby gasifying the chemical to disinfect the sterilizing gas, deodorizing gas, or fragrance. At the same time, the exhaust fan 7 is rotationally driven to diffuse the sterilizing gas generated in the box body 2 from the box body 2 into the room 13 through the exhaust port 8 alone.

これにより、タイマで設定した所定時間、除菌ガス等を室内13へ拡散させ、室内13を殺菌、除菌、脱臭又は芳香する。   Accordingly, the sterilization gas or the like is diffused into the room 13 for a predetermined time set by the timer, and the room 13 is sterilized, sterilized, deodorized, or fragranced.

ここで、薬剤を二酸化塩素にした場合には、微生物の殺菌・除菌に必要な二酸化塩素ガスの濃度が0.1ppm以上で殺菌・除菌効果があると考えられるが、好ましくは1ppm以上であり、人が誤って殺菌・除菌中に室内13へ入っても安全な濃度として1ppm〜10ppmの範囲が好適である。   Here, when the chemical is chlorine dioxide, it is considered that the concentration of chlorine dioxide gas necessary for sterilization and sterilization of microorganisms is 0.1 ppm or more, and there is a sterilization and sterilization effect. There is a range of 1 ppm to 10 ppm as a safe concentration even if a person accidentally enters the room 13 during sterilization and sterilization.

具体的には、室内13の広さが6〜10坪の割合で薬剤拡散装置1を1台設置することにより、1時間で除菌ガスを室内13の隅々まで行き渡らせ、時間の経過に伴って除菌ガスの濃度が上がり、室内13の空気や機器において細菌、カビを2〜6時間で死滅させることができる。   Specifically, by installing one drug diffusion device 1 at a ratio of 6 to 10 tsubo in the area of the room 13, the sterilization gas is spread to every corner of the room 13 in 1 hour, and over time Along with this, the concentration of the sterilizing gas is increased, and bacteria and molds can be killed in 2 to 6 hours in the air and equipment in the room 13.

以下、流通口を排気口8のみにした本発明の薬剤拡散装置1(装置A)と、流通口を吸気口16と排気口8にした対比用の薬剤拡散装置17(装置B)とを具体的に比較して説明する。   Hereinafter, the drug diffusion apparatus 1 (apparatus A) of the present invention in which only the exhaust port 8 is used as the flow outlet and the drug diffusion apparatus 17 (apparatus B) for comparison in which the flow inlet is used as the intake port 16 and the exhaust port 8 will be specifically described. Comparison will be described.

流通口を排気口8のみにした本発明の薬剤拡散装置1(装置A)は、図5に示す如く、8Wの紫外線ランプ6を2本配すると共に、120mm角の排気口8に風量1.4m/minの排気ファン7を設置しており、一方、流通口を吸気口16と排気口8にした対比用の薬剤拡散装置17(装置B)は、図6に示す如く、本発明の薬剤拡散装置1(装置A)と同じ構成を備えると共に、更に両側面に所定の吸気口16を形成している。なお、図1〜図4と同一の符号を付した部分は同一物を表わしている。又、夫々の装置に使用する薬剤は、2Kgで濃度15000ppmの二酸化塩素ゲルであり、直方体容器5(内径W190×D105×H110mm)に入れている。更に、夫々の薬剤拡散装置1を配置する室内13は、広さ17.4m(約10.7畳)、高さ2.5mで体積43.2mであり、ドアの反対側で高さ約2000mmの位置に薬剤拡散装置1を配置している。更に又、室内13の密閉には、換気扇口とドアの換気口を発砲スチロールで塞ぎ、ドア下部の隙間に目張りをした。 As shown in FIG. 5, the drug diffusion device 1 (device A) of the present invention having only the exhaust port 8 as the circulation port is provided with two 8 W ultraviolet lamps 6, and the air volume 1. On the other hand, a drug diffusion device 17 (device B) for comparison, in which a 4 m 3 / min exhaust fan 7 is installed and the flow ports are the intake port 16 and the exhaust port 8, as shown in FIG. While having the same configuration as the drug diffusing apparatus 1 (apparatus A), predetermined intake ports 16 are formed on both side surfaces. In addition, the part which attached | subjected the code | symbol same as FIGS. 1-4 represents the same thing. Moreover, the chemical | medical agent used for each apparatus is the chlorine dioxide gel of 25000g and a density | concentration of 15000 ppm, and has put into the rectangular parallelepiped container 5 (inner diameter W190 * D105 * H110mm). Furthermore, the room 13 in which each drug diffusion device 1 is arranged has a size of 17.4 m 2 (about 10.7 tatami mats), a height of 2.5 m, a volume of 43.2 m 3 , and a height on the opposite side of the door. The drug diffusion device 1 is disposed at a position of about 2000 mm. Furthermore, for sealing the interior of the room 13, the ventilation fan and the door's ventilation opening were closed with foamed polystyrene, and the gap in the lower part of the door was marked.

このような状態で、装置横上角、部屋中央、ドア横の三ヶ所でガス濃度を経時的に測定し、下記のような結果を得た。

Figure 0004394584
In such a state, the gas concentration was measured over time at three locations, the upper horizontal corner of the apparatus, the center of the room, and the side of the door, and the following results were obtained.
Figure 0004394584

上記の表1と図7のグラフにより、流通口を排気口8のみにした本発明の薬剤拡散装置1(装置A)と、流通口を吸気口16と排気口8にした対比用の薬剤拡散装置17(装置B)は、3時間を経過後、ほぼ一定の濃度になっており、本発明の薬剤拡散装置1(装置A)は、薬剤拡散装置17(装置B)に比べ、濃度が平均して0.3ppm高くなっている。なお、流通口を排気口8のみにした本発明の薬剤拡散装置1(装置A)が、流通口を吸気口16と排気口8にした対比用の薬剤拡散装置17(装置B)に比べて、二酸化塩素の濃度が高くなる理由は、本発明の薬剤拡散装置1(装置A)の気流の流れが穏やかであり、紫外線ランプ6による二酸化塩素ガスの反応時間が長くなると共に、ボックス本体2内を真空状態にして風の影響を最小限にしているためと考えられる。   From the above Table 1 and the graph of FIG. 7, the drug diffusion device 1 (device A) of the present invention having only the exhaust port 8 as the flow port and the drug diffusion for comparison with the intake port 16 and the exhaust port 8 as the flow ports. The device 17 (device B) has a substantially constant concentration after 3 hours, and the drug diffusion device 1 (device A) of the present invention has an average concentration compared to the drug diffusion device 17 (device B). And 0.3 ppm higher. The drug diffusion device 1 (device A) of the present invention having only the exhaust port 8 as a circulation port is compared with the drug diffusion device 17 for comparison (device B) having a flow port as the intake port 16 and the exhaust port 8. The reason why the concentration of chlorine dioxide is high is that the flow of the air flow of the drug diffusion device 1 (device A) of the present invention is gentle, the reaction time of chlorine dioxide gas by the ultraviolet lamp 6 becomes long, and the inside of the box body 2 This is considered to be because the influence of the wind is minimized by making the vacuum state.

これにより、流通口を排気口8のみにした本発明の薬剤拡散装置1(装置A)は、流通口を吸気口16と排気口8にした対比用の薬剤拡散装置17(装置B)に比べ、濃度が平均して0.3ppm高く、薬剤を好適に拡散させることが明らかである。   As a result, the drug diffusion device 1 (device A) of the present invention having only the exhaust port 8 as the circulation port is compared with the drug diffusion device 17 for comparison (device B) having the flow port as the intake port 16 and the exhaust port 8. It is clear that the concentration is 0.3 ppm higher on average and that the drug is suitably diffused.

次に、薬剤拡散装置1の構成を変更すると共に、室内13の代わりにロッカー18で使用した場合において、流通口を排気口19のみにした本発明の薬剤拡散装置20(装置C)と、流通口を吸気口21と排気口19にした対比用の薬剤拡散装置22(装置D)とを具体的に比較して説明する。   Next, the configuration of the drug diffusing device 1 is changed, and the drug diffusing device 20 (device C) of the present invention in which the flow port is only the exhaust port 19 when used in the locker 18 instead of the room 13, and the flow The comparison drug diffusion device 22 (device D) having the inlet port 21 and the exhaust port 19 as the ports will be specifically described.

流通口を排気口19のみにした本発明の薬剤拡散装置20(装置C)は、図8に示す如く、4Wの紫外線ランプ23を配すると共に、ボックス本体24の下面に排気口19として回転数2600回転/min、風量0.7m/minの排気ファン25を設置しており、一方、流通口を吸気口21と排気口19にした対比用の薬剤拡散装置22(装置D)は、本発明の薬剤拡散装置20(装置C)と同じ構成を備えると共に、更に一側面に所定の吸気口21を形成している。なお、図1〜図4と同一の符号を付した部分は同一物を表わしている。又、夫々の装置に使用する薬剤は、500gで濃度10000ppmの二酸化塩素であり、所定の容器26に入れている。更に、夫々の薬剤拡散装置1を配置するロッカー18は図10に示す如く一般的なものであり、ロッカー18の上段に薬剤拡散装置20,22を配置している。 As shown in FIG. 8, the drug diffusion device 20 (device C) of the present invention having only the exhaust port 19 as the circulation port is provided with a 4 W ultraviolet lamp 23 and the number of revolutions as the exhaust port 19 on the lower surface of the box body 24. An exhaust fan 25 having an air flow rate of 2600 rpm / min and an air volume of 0.7 m 3 / min is installed. On the other hand, a contrasting drug diffusion device 22 (device D) having a circulation port as an intake port 21 and an exhaust port 19 is While having the same configuration as the drug diffusion device 20 (device C) of the invention, a predetermined air inlet 21 is further formed on one side. In addition, the part which attached | subjected the code | symbol same as FIGS. 1-4 represents the same thing. Moreover, the chemical | medical agent used for each apparatus is the chlorine dioxide with a density | concentration of 10000 ppm at 500 g, and has put into the predetermined container 26. FIG. Furthermore, the lockers 18 in which the respective drug diffusion devices 1 are arranged are general as shown in FIG. 10, and the drug diffusion devices 20 and 22 are arranged in the upper stage of the lockers 18.

このような状態で、ロッカー18上、ロッカー18下の二ヶ所でガス濃度を経時的に測定し、下記のような結果を得た。なお、下記の表2と図11は2回試験を行ったもの及びその平均値を示している。

Figure 0004394584
In such a state, the gas concentration was measured over time at two locations on the rocker 18 and below the rocker 18, and the following results were obtained. In addition, Table 2 and FIG. 11 below show the results of two tests and their average values.
Figure 0004394584

上記の表2と図11のグラフにより、流通口を排気口19のみにした本発明の薬剤拡散装置20(装置C)と、流通口を吸気口21と排気口19にした対比用の薬剤拡散装置22(装置D)は、120分を経過後、ほぼ一定の濃度になっており、本発明の薬剤拡散装置20(装置C)は、薬剤拡散装置22(装置D)に比べ、120分後、濃度が平均して2.4ppm高くなっている。なお、流通口を排気口19のみにした本発明の薬剤拡散装置20(装置C)が、流通口を吸気口21と排気口19にした対比用の薬剤拡散装置22(装置D)に比べて、二酸化塩素の濃度が高くなる理由は、先の例とほぼ同様に、本発明の薬剤拡散装置20(装置C)の気流の流れが穏やかになり、紫外線ランプ23による二酸化塩素ガスの反応時間が長くなると共に、ボックス本体2内を真空状態にして風の影響を最小限にしているためと考えられる。   From the above Table 2 and the graph of FIG. 11, the drug diffusion device 20 (device C) of the present invention having only the exhaust port 19 as the flow port and the drug diffusion for comparison with the flow port as the intake port 21 and the exhaust port 19. The device 22 (device D) has a substantially constant concentration after 120 minutes, and the drug diffusion device 20 (device C) of the present invention is 120 minutes later than the drug diffusion device 22 (device D). The concentration is 2.4 ppm higher on average. It should be noted that the drug diffusion device 20 (device C) of the present invention having only the exhaust port 19 as a circulation port is compared with the drug diffusion device 22 for comparison (device D) having the intake port 21 and the exhaust port 19 as distribution ports. The reason why the concentration of chlorine dioxide becomes high is that, as in the previous example, the flow of the air flow of the drug diffusion device 20 (device C) of the present invention becomes gentle, and the reaction time of chlorine dioxide gas by the ultraviolet lamp 23 is reduced. This is considered to be due to the fact that the inside of the box body 2 is evacuated to minimize the influence of the wind.

これにより、流通口を排気口19のみにした本発明の薬剤拡散装置20(装置C)は、流通口を吸気口21と排気口19にした対比用の薬剤拡散装置22(装置D)に比べ、濃度が平均して2.4ppm高く、薬剤を好適に拡散させることが明らかである。   As a result, the drug diffusion device 20 (device C) of the present invention having only the exhaust port 19 as a circulation port is compared with the drug diffusion device 22 (device D) for comparison with the intake port 21 and the exhaust port 19 as the circulation ports. It is clear that the concentration is 2.4 ppm higher on average and that the drug is suitably diffused.

続いて、ボックス本体2の排気口8を容器5の開放口4よりも下方に配置した薬剤拡散装置27(装置E)と、ボックス本体2の排気口8を容器5の開放口4よりも上方に配置した対比用の薬剤拡散装置28(装置F)とを具体的に比較して説明する。   Subsequently, the drug diffusion device 27 (device E) in which the exhaust port 8 of the box body 2 is disposed below the opening 4 of the container 5, and the exhaust port 8 of the box body 2 is above the opening 4 of the container 5. The comparison drug diffusion device 28 (device F) arranged in FIG.

ボックス本体2の排気口8を容器5の開放口4よりも下方に配置した薬剤拡散装置27(装置E)は、図12に示す如く、架台3の上に容器5を配置してボックス本体2の排気口8を容器5の開放口4よりも下方に配置し、先の薬剤拡散装置17(装置B)とほぼ同様に、8Wの紫外線ランプ6を2本配すると共に、120mm角の排気口8に風量1.4m/minの排気ファン7を設置し、両側面に所定の吸気口16を形成している。一方、ボックス本体2の排気口8を容器5の開放口4よりも上方に配置した対比用の薬剤拡散装置28(装置F)は、図13に示す如く、薬剤拡散装置27(装置E)と同じ構成を備えると共に、架台3を取り除いて容器5を直接ボックス本体2の底面に配置し、ボックス本体2の排気口8を容器5の開放口4よりも上方に配置している。又、夫々の装置に使用する薬剤は、2Kgで濃度15000ppmの二酸化塩素ゲルであり、直方体容器5(内径W190×D105×H110mm)に入れている。更に、夫々の薬剤拡散装置1を配置する室内13は、広さ17.4m(約10.7畳)、高さ2.5mで体積43.2mであり、ドアの反対側で高さ約2000mmの位置に薬剤拡散装置1を配置している。更に又、室内13の密閉には、換気扇口とドアの換気口を発砲スチロールで塞ぎ、ドア下部の隙間に目張りをした。 The drug diffusion device 27 (device E) in which the exhaust port 8 of the box body 2 is disposed below the open port 4 of the container 5 has the container 5 disposed on the mount 3 as shown in FIG. Are disposed below the opening 4 of the container 5, and two 8W ultraviolet lamps 6 are arranged in the same manner as the drug diffusion device 17 (device B), and a 120 mm square exhaust port is provided. 8, an exhaust fan 7 having an air volume of 1.4 m 3 / min is installed, and predetermined intake ports 16 are formed on both side surfaces. On the other hand, a contrasting drug diffusion device 28 (device F) in which the exhaust port 8 of the box body 2 is disposed above the opening 4 of the container 5 is shown in FIG. 13 as a drug diffusion device 27 (device E). While having the same configuration, the gantry 3 is removed, the container 5 is disposed directly on the bottom surface of the box body 2, and the exhaust port 8 of the box body 2 is disposed above the opening 4 of the container 5. Moreover, the chemical | medical agent used for each apparatus is the chlorine dioxide gel of 25000g and a density | concentration of 15000 ppm, and has put into the rectangular parallelepiped container 5 (inner diameter W190 * D105 * H110mm). Furthermore, the room 13 in which each drug diffusion device 1 is arranged has a size of 17.4 m 2 (about 10.7 tatami mats), a height of 2.5 m, a volume of 43.2 m 3 , and a height on the opposite side of the door. The drug diffusion device 1 is disposed at a position of about 2000 mm. Furthermore, for sealing the interior of the room 13, the ventilation fan and the door's ventilation opening were closed with foamed polystyrene, and the gap in the lower part of the door was marked.

このような状態で、装置横上角、部屋中央、ドア横の三ヶ所でガス濃度を経時的に測定し、下記のような結果を得た。

Figure 0004394584
In such a state, the gas concentration was measured over time at three locations, the upper horizontal corner of the apparatus, the center of the room, and the side of the door, and the following results were obtained.
Figure 0004394584

上記の表3と図14のグラフにより、ボックス本体2の排気口8を容器5の開放口4よりも下方に配置した薬剤拡散装置27(装置E)は、3時間を経過後、ほぼ一定の濃度になっており、流通口を吸気口16と排気口8にした対比用の薬剤拡散装置28(装置F)は、4時間を経過後、ほぼ一定の濃度になり、薬剤拡散装置27(装置E)は、対比用の薬剤拡散装置28(装置F)に比べ、迅速に拡散している。又、薬剤拡散装置27(装置E)は、対比用の薬剤拡散装置28(装置F)に比べ、4時間後の濃度が平均して0.14ppm高くなっている。なお、薬剤拡散装置27(装置E)が、対比用の薬剤拡散装置28(装置F)に比べて、二酸化塩素を迅速に拡散させる理由は、排気ファン7の風が容器5の開放口4に直接当たることをなくして二酸化塩素ガスを効率的に発生させると共に、室内13の空間に対し、二酸化塩素ガスを均一に流しているためと考えられる。   According to Table 3 and the graph of FIG. 14, the drug diffusion device 27 (device E) in which the exhaust port 8 of the box body 2 is disposed below the open port 4 of the container 5 is substantially constant after 3 hours. The concentration of the drug diffusion device 28 (device F) for comparison with the intake port 16 and the exhaust port 8 being the distribution port becomes a substantially constant concentration after 4 hours, and the drug diffusion device 27 (device) E) is diffusing rapidly compared to the contrasting drug diffusion device 28 (device F). Further, the drug diffusion device 27 (device E) has an average concentration of 0.14 ppm higher after 4 hours than the comparison drug diffusion device 28 (device F). The reason why the drug diffusion device 27 (device E) diffuses chlorine dioxide more quickly than the comparison drug diffusion device 28 (device F) is that the wind of the exhaust fan 7 flows into the opening 4 of the container 5. This is considered to be because chlorine dioxide gas is efficiently generated without direct contact, and the chlorine dioxide gas is made to flow uniformly into the space of the room 13.

これにより、ボックス本体2の排気口8を容器5の開放口4よりも下方に配置した薬剤拡散装置27(装置E)は、ボックス本体2の排気口8を容器5の開放口4よりも上方に配置した対比用の薬剤拡散装置28(装置F)に比べ、二酸化塩素が迅速に拡散し、薬剤を好適に拡散させることが明らかである。   Thereby, in the drug diffusion device 27 (device E) in which the exhaust port 8 of the box body 2 is disposed below the opening 4 of the container 5, the exhaust port 8 of the box body 2 is positioned above the opening 4 of the container 5. It is clear that chlorine dioxide diffuses rapidly and the drug is suitably diffused, as compared to the contrasting drug diffusion device 28 (device F) arranged in the above.

このように、実施の形態例の薬剤拡散装置1によれば、ボックス本体2に、空気を外部から供給する吸気口16を設けることなく、排気ファン7を備えた排気口8のみを設けて二酸化塩素ガスを外部へ拡散させるので、吸気口16及び排気口8を備えて排気ファン7により薬剤を拡散させる場合に比べ、薬剤を好適に拡散させ、結果的に、薬剤の濃度を容易に上げることができる。ここで、排気ファン7の風量は毎分0.5m〜10.0mが好ましく、これよりも風量を大きくする場合には、薬剤の減少量が大きくなり、風量によっては薬剤の濃度が上がらない現象が生じる。又、風量を小さくする場合には、薬剤を好適に拡散させることができない。更に、排気ファン7の風量は毎分1.0m〜3.0mにした場合に最も好適に薬剤を拡散させることができる。 As described above, according to the drug diffusing device 1 of the embodiment , the box body 2 is provided with only the exhaust port 8 provided with the exhaust fan 7 without providing the intake port 16 for supplying air from the outside. Since chlorine gas is diffused to the outside , the drug is preferably diffused and the drug concentration is easily increased as compared with the case where the drug is diffused by the exhaust fan 7 provided with the intake port 16 and the exhaust port 8. Can do. Here, the air volume of the exhaust fan 7 is preferably min 0.5m 3 ~10.0m 3, in the case of increasing the air volume than this, the decrease of the drug is increased, rise the concentration of the drug by the air volume No phenomenon occurs. Further, when the air volume is reduced, the drug cannot be diffused suitably. Furthermore, the air volume of the exhaust fan 7 can be most suitably diffusing agent when the min 1.0m 3 ~3.0m 3.

又、排気口8を、容器5の開放口4よりも下方に配置すると、排気口8を容器5の開放口4より上方に配置した場合に比べて、薬剤を迅速に拡散させ、結果的に、薬剤の濃度を容易且つ好適に均一化すると共に、薬剤の濃度に上げるまでの時間を一層短縮することができる。   Further, if the exhaust port 8 is disposed below the opening 4 of the container 5, compared with the case where the exhaust port 8 is disposed above the opening 4 of the container 5, the drug is diffused more quickly, and as a result. The concentration of the drug can be easily and suitably uniformed, and the time required for increasing the drug concentration can be further shortened.

ボックス本体2の開閉ドア12を密閉可能にすると、ボックス本体2の真空度を高めるので、薬剤を一層好適に拡散させることができる。   If the opening / closing door 12 of the box body 2 can be sealed, the degree of vacuum of the box body 2 is increased, so that the drug can be more suitably diffused.

容器5に入れる薬剤を、二酸化塩素溶液又は二酸化塩素を溶存させたゲル状固形物のいずれかにすると、クリーンフィルタの如く他の殺菌・除菌剤を併用することを不要にし、空気は勿論、機器や部品等の裏面や隙間などの部分であっても好適に殺菌・除菌することができる。又、二酸化塩素ガスによれば、汚染された作業台や食品を好適に殺菌・除菌すると共に、汚染により発生する臭いを抑制することができる。   If the medicine to be put in the container 5 is either a chlorine dioxide solution or a gel-like solid in which chlorine dioxide is dissolved, it is unnecessary to use other sterilizing / disinfecting agents in combination with a clean filter. It is possible to suitably sterilize and disinfect parts such as the back surface and gaps of parts and parts. Moreover, according to the chlorine dioxide gas, it is possible to suitably sterilize and disinfect the contaminated work table and food, and to suppress the odor generated by the contamination.

図15〜図17は参考例を示すもので、実施の形態例の薬剤拡散装置1から紫外線ランプ6を無くしたものであり、実施の形態例と同一の符号を付した部分は同一物を表わしている。 15 to 17 is intended to show a reference example, which has lost the ultraviolet lamp 6 from the drug diffusing apparatus 1 of the embodiment, portions denoted by the same reference numerals as embodiment example represents the same product ing.

参考例の薬剤拡散装置29は、内部空間を形成するボックス本体2を備え、ボックス本体2の内部下面には、所定高さを有する架台3を設置し、架台3の上面には、上方に開放口4を形成したプラスチックもしくは金属製の容器5を交換可能に配置している。ここで、容器5は、直径15〜30cmの径の開放口4を有する円柱形か、それに近い開放口4を有する直方体で形成されており、容器5の内部には、所定濃度で揮発性の殺菌剤、脱臭剤又は芳香剤(薬剤)を収容している。 The drug diffusion device 29 of the reference example includes a box body 2 that forms an internal space, and a frame 3 having a predetermined height is installed on the inner lower surface of the box body 2, and the upper surface of the frame 3 is opened upward. A plastic or metal container 5 in which the mouth 4 is formed is disposed so as to be replaceable. Here, the container 5 is formed in a cylindrical shape having an open port 4 having a diameter of 15 to 30 cm or a rectangular parallelepiped having an open port 4 close thereto, and inside the container 5 is volatile at a predetermined concentration. Contains disinfectant, deodorant or fragrance (medicine).

ボックス本体2の側方正面の下部には、空気を外部と流通させる流通口を形成するよう、排気ファン7を備えた排気口8を備えている。ここで排気ファン7は、容器5の開放口4よりも下方に位置して風向きをボックス本体2の内部から外部へ向けるようにし、又、回転数を毎分1×10回転〜5×10回転にし、風量を毎分0.5m〜10.0m、好ましくは毎分1.0m〜3.0mにしている。なお、排気ファン7を備えた排気口8は、ボックス本体2の底面に配置してもよい。 An exhaust port 8 including an exhaust fan 7 is provided in a lower portion of the front side of the box body 2 so as to form a circulation port through which air is circulated to the outside. Here, the exhaust fan 7 is positioned below the opening 4 of the container 5 so that the air direction is directed from the inside of the box body 2 to the outside, and the rotation speed is 1 × 10 3 rotations to 5 × 10 5 minutes per minute. 3 to rotate, every minute air volume 0.5 m 3 ~10.0M 3, preferably in the min 1.0m 3 ~3.0m 3. The exhaust port 8 provided with the exhaust fan 7 may be disposed on the bottom surface of the box body 2.

ボックス本体2の床面で架台3の下部には、排気ファン7に接続される電気制御部9を配置しており、電気制御部9は、ボックス本体2の正面下部にスイッチ10を備えると共に内部にタイマー機構と安全機構とを備え、タイマー機構は、排気ファン7の駆動時間等を制御すると共に、安全機構は、雷等により過電流が流れた場合に安全に対応し得るようにしている。ここで、電気制御部9は、外部の電源(図示せず)に配線(図示せず)を介して接続されており、外部の電源に接続される配線は、ボックス本体2の裏面に形成された配線口(図示せず)を通すようになっている。なお、配線口は、耐薬品性のパッキン等で穴埋めすることが好ましい。   An electric control unit 9 connected to the exhaust fan 7 is disposed on the floor surface of the box body 2 at the lower part of the gantry 3, and the electric control unit 9 includes a switch 10 at the lower front portion of the box body 2 and an internal portion. Are provided with a timer mechanism and a safety mechanism. The timer mechanism controls the driving time of the exhaust fan 7 and the like, and the safety mechanism can safely cope with an overcurrent caused by lightning or the like. Here, the electric control unit 9 is connected to an external power source (not shown) via wiring (not shown), and the wiring connected to the external power source is formed on the back surface of the box body 2. Through the wiring port (not shown). The wiring port is preferably filled with a chemical resistant packing or the like.

又、ボックス本体2の正面上部もしくは側面上部には、ドアノブ11を備えて開閉し得る開閉ドア12を備えており、開閉ドア12は、周囲に耐薬品性ゴムパッキンやシリコン樹脂の密着材を配し、ボックス本体2に対して密閉可能にしている。   The box body 2 is provided with an opening / closing door 12 that can be opened and closed with a door knob 11 at the front upper portion or side surface upper portion, and the opening / closing door 12 is provided with a chemical-resistant rubber packing or a silicone resin adhesion material around it. The box body 2 can be sealed.

以下、参考例の作用を説明する。 The operation of the reference example will be described below.

参考例の薬剤拡散装置29を使用して揮発性の殺菌剤、脱臭剤又は芳香剤等の薬剤を拡散させる場合には、予め、ボックス本体2内の架台3に、薬剤を収容した容器5を配置し、薬剤を拡散させる室内13の壁面上部に、排気口8を室内13側に向けて薬剤拡散装置29を配置し、室内13の出入口14の扉15を閉じる。 In the case where a drug such as a volatile bactericide, deodorant or fragrance is diffused using the drug diffusion device 29 of the reference example , the container 5 containing the drug is previously placed on the mount 3 in the box body 2. The medicine diffusion device 29 is arranged on the upper surface of the wall surface of the room 13 where the medicine is diffused and the exhaust port 8 faces the room 13 side, and the door 15 of the entrance / exit 14 of the room 13 is closed.

続いて、スイッチ10を入れ、電気制御部9のタイマを作動させると共に、排気ファン7に電源を供給する。   Subsequently, the switch 10 is turned on, the timer of the electric control unit 9 is operated, and power is supplied to the exhaust fan 7.

電源を排気ファン7に供給すると、排気ファン7は、回転駆動することにより、ボックス本体2内で発生した殺菌剤、脱臭剤又は芳香剤等の薬剤を排気口8のみを介してボックス本体2から室内13へ拡散させる。   When the power is supplied to the exhaust fan 7, the exhaust fan 7 is rotationally driven, so that the sterilizing agent, the deodorizing agent, the fragrance, or the like generated in the box body 2 is discharged from the box body 2 only through the exhaust port 8. It diffuses into the room 13.

これにより、タイマで設定した所定時間、殺菌剤、脱臭剤又は芳香剤等の薬剤を室内13へ拡散させる。   Thereby, chemical | medical agents, such as a disinfectant, a deodorizing agent, or an aromatic agent, are spread | diffused in the room | chamber 13 for the predetermined time set with the timer.

従って、参考例の薬剤拡散装置29によれば、空気を外部と流通させる流通口を、排気ファン7を備えた排気口8のみにするので、吸気口16及び排気口8を備えて排気ファン7により薬剤を拡散させる場合に比べ、薬剤を好適に拡散させ、結果的に、薬剤の濃度を容易に上げることができる。 Therefore, according to the drug diffusing device 29 of the reference example, the only circulation port through which air is circulated to the outside is the exhaust port 8 provided with the exhaust fan 7. Therefore, the exhaust fan 7 is provided with the intake port 16 and the exhaust port 8. Compared with the case where the drug is diffused by the above, the drug is preferably diffused, and as a result, the concentration of the drug can be easily increased.

又、排気口8を、容器5の開放口4よりも下方に配置すると、排気口8を容器5の開放口4より上方に配置した場合に比べて、薬剤を迅速に拡散させ、結果的に、薬剤の濃度を容易且つ好適に均一化すると共に、薬剤の濃度に上げるまでの時間を一層短縮することができる。   Further, if the exhaust port 8 is disposed below the opening 4 of the container 5, compared with the case where the exhaust port 8 is disposed above the opening 4 of the container 5, the drug is diffused more quickly, and as a result. The concentration of the drug can be easily and suitably uniformed, and the time required for increasing the drug concentration can be further shortened.

ボックス本体2の開閉ドア12を密閉可能にすると、ボックス本体2の真空度を高めるので、薬剤を一層好適に拡散させることができる。   If the opening / closing door 12 of the box body 2 can be sealed, the degree of vacuum of the box body 2 is increased, so that the drug can be more suitably diffused.

なお、本発明は、上述の実施の形態にのみ限定されるものではなく、薬剤拡散装置を、カビ類の多さや室内の広さにより複数台設置して同時に使用しても良いこと、その他、本発明の要旨を逸脱しない範囲内において種々変更を加え得ることは勿論である。   The present invention is not limited only to the above-described embodiment, and a plurality of drug diffusion devices may be installed and used at the same time depending on the number of molds and the size of the room. Of course, various modifications can be made without departing from the scope of the present invention.

本発明の実施の形態例を示す概略斜視図である。It is a schematic perspective view showing an embodiment of the present invention. 本発明の実施の形態例を示す概略正面図であるIt is a schematic front view showing an embodiment of the present invention 図2のIII−III方向の矢視図である。FIG. 3 is an arrow view in the III-III direction of FIG. 2. 本発明の薬剤拡散装置を室内に備える位置を示す概略図である。It is the schematic which shows the position which equips the room | chamber interior with the chemical | medical agent diffusion apparatus of this invention. 流通口を排気口のみにした本発明の薬剤拡散装置(装置A)を示す概略斜視図である。It is a schematic perspective view which shows the chemical | medical agent diffusion apparatus (apparatus A) of this invention which made the distribution | circulation port only the exhaust port. 流通口を吸気口と排気口にした対比用の薬剤拡散装置(装置B)を示す概略斜視図である。It is a schematic perspective view which shows the chemical | medical agent diffusion apparatus (apparatus B) for a comparison which made the distribution | circulation port the inlet port and the exhaust port. 図5の本発明の薬剤拡散装置(装置A)によるガス濃度と、図6の対比用の薬剤拡散装置(装置B)によるガス濃度とを対比した平均値のグラフである。6 is a graph of an average value obtained by comparing the gas concentration by the drug diffusion device (device A) of the present invention in FIG. 5 with the gas concentration by the drug diffusion device for comparison (device B) in FIG. 6. 流通口を排気口のみにした本発明の他の薬剤拡散装置(装置C)を示す概略斜視図である。It is a schematic perspective view which shows the other chemical | medical agent diffusion apparatus (apparatus C) of this invention which made the circulation port only the exhaust port. 流通口を吸気口と排気口にした対比用の薬剤拡散装置(装置D)を示す概略斜視図である。It is a schematic perspective view which shows the chemical | medical agent diffusion apparatus (apparatus D) for a comparison which made the distribution | circulation port the inlet port and the exhaust port. 薬剤拡散装置をロッカーに配置した状態を示す概念図である。It is a conceptual diagram which shows the state which has arrange | positioned the chemical | medical agent diffusion apparatus to the locker. 図8の本発明の他の薬剤拡散装置(装置C)によるガス濃度と、図9の対比用の薬剤拡散装置(装置D)によるガス濃度とを対比した平均値のグラフである。FIG. 10 is a graph of an average value obtained by comparing the gas concentration by another drug diffusion device (device C) of the present invention in FIG. 8 with the gas concentration by the drug diffusion device for comparison (device D) in FIG. 9. 排気口を容器の開放口よりも下方に配置した薬剤拡散装置(装置E)を示す概略斜視図である。It is a schematic perspective view which shows the chemical | medical agent diffusion apparatus (apparatus E) which has arrange | positioned the exhaust port below the open port of the container. 排気口を容器の開放口よりも上方に配置した対比用の薬剤拡散装置(装置F)を示す概略斜視図である。It is a schematic perspective view which shows the chemical | medical agent diffusion apparatus (apparatus F) for a comparison which has arrange | positioned the exhaust port above the opening of a container. 図12の薬剤拡散装置(装置E)によるガス濃度と、図13の対比用の薬剤拡散装置(装置F)によるガス濃度とを対比したグラフである。It is the graph which contrasted the gas concentration by the chemical | medical agent diffusion apparatus (apparatus E) of FIG. 12, and the gas concentration by the chemical | medical agent diffusion apparatus (apparatus F) for a comparison of FIG. 参考例を示す概略斜視図である。 It is a schematic perspective view which shows a reference example . 参考例を示す概略正面図である It is a schematic front view which shows a reference example 図16のXVII−XVII方向の矢視図である。It is an arrow directional view of the XVII-XVII direction of FIG.

符号の説明Explanation of symbols

2 ボックス本体
3 架台
4 開放口
5 容器
6 紫外線ランプ
7 排気ファン
8 排気口
12 開閉ドア
19 排気口
23 紫外線ランプ
24 ボックス本体
25 排気ファン
26 容器
2 Box body 3 Base 4 Open port 5 Container 6 UV lamp 7 Exhaust fan 8 Exhaust port 12 Open / close door 19 Exhaust port 23 UV lamp 24 Box body 25 Exhaust fan 26 Container

Claims (2)

薬剤を収容し且つ上方に開放口を形成した容器と、該容器を交換可能に配置するボックス本体と、前記ボックス本体内部で前記容器の上方に対向配置される紫外線ランプと、前記ボックス本体に設置される排気ファンとを備え、
前記容器に入れる薬剤を、二酸化塩素溶液又は二酸化塩素を溶存させたゲル状固形物のいずれかにし、
前記ボックス本体に、空気を外部から供給する吸気口を設けることなく、排気ファンを備えた排気口のみを設けて二酸化塩素ガスを外部へ拡散させると共に、前記排気口を、容器の開放口よりも下方に配したことを特徴とする薬剤拡散装置。
A container that contains a medicine and has an open opening in the upper part, a box main body in which the container is replaceably disposed, an ultraviolet lamp that is disposed above the container inside the box main body, and is installed in the box main body With an exhaust fan,
The drug placed in the container is either a chlorine dioxide solution or a gel-like solid in which chlorine dioxide is dissolved,
Without providing an air inlet for supplying air from the outside to the box body , only an exhaust port provided with an exhaust fan is provided to diffuse chlorine dioxide gas to the outside, and the exhaust port is more than the opening of the container. A drug diffusion device characterized by being arranged below .
ボックス本体の開閉ドアを密閉可能にした請求項に記載の薬剤拡散装置。 The drug diffusion device according to claim 1 , wherein the open / close door of the box body can be sealed.
JP2005003913A 2005-01-11 2005-01-11 Drug diffusion device Expired - Fee Related JP4394584B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005003913A JP4394584B2 (en) 2005-01-11 2005-01-11 Drug diffusion device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005003913A JP4394584B2 (en) 2005-01-11 2005-01-11 Drug diffusion device

Publications (2)

Publication Number Publication Date
JP2006191960A JP2006191960A (en) 2006-07-27
JP4394584B2 true JP4394584B2 (en) 2010-01-06

Family

ID=36798489

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005003913A Expired - Fee Related JP4394584B2 (en) 2005-01-11 2005-01-11 Drug diffusion device

Country Status (1)

Country Link
JP (1) JP4394584B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104321137B (en) * 2013-04-17 2016-03-30 株式会社Fmi Chlorine dioxide gas generating device and sterilization box for medical equipment

Also Published As

Publication number Publication date
JP2006191960A (en) 2006-07-27

Similar Documents

Publication Publication Date Title
CN107921156B (en) Sterilization equipment with a configuration that selectively performs different disinfection modes inside and outside the equipment
JP5469281B2 (en) Ozonizer
CA2905956C (en) Apparatus and process for focused gas phase application of biocide
KR20110108509A (en) Medical Disinfection Device for Hydrogen Peroxide Using Ultrasonic Humidification Principle
JP2004016649A (en) Sterilization method, sterilization apparatus and equipment using the same, buildings, moving objects
KR200454036Y1 (en) Sterilizers for sterilizing shoeless doors and open areas
JP2004033498A (en) Environmental adjustment method and environmental adjustment device
KR102203323B1 (en) Air circulation sterilizer
JP2005342314A (en) Sterilizer
JP4394584B2 (en) Drug diffusion device
KR102384363B1 (en) Multi sterilizer having air sterilization function
KR102350241B1 (en) Sterilization and drying, deodorization device for mask
JP4060221B2 (en) Disinfection device
CN106178059A (en) Sterilizing taste removal all-in-one and sterilizing taste removal method thereof
JP6947458B1 (en) Indoor sterilizer
KR102141131B1 (en) chlorine dioxide gas generating apparatus
KR102294999B1 (en) Toilet sanitary apparatus with cleaning, sterilization and deodorization functions
KR20220096288A (en) Portable sterilization device
US20210338857A1 (en) Air-Water-Food-Fabric-Space-Utility Sanitizer
JP2022525181A (en) Prosthodontic accessory sterilizer
HK40069625A (en) Germicidal apparatuses with configurations to selectively conduct different disinfection modes interior and exterior to the apparatus
JP3091374U (en) Sterilization locker
JP2003220122A (en) Deodorizing method and apparatus
JP2024065604A (en) Ozone sterilization booth
ES1249519U (en) STERILIZING EQUIPMENT OF TEXTILE GARMENTS. (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070131

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070131

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090715

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090721

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090902

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20091006

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20091015

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121023

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121023

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131023

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees